Article Information
History
- September 17, 2020.
Article Versions
- You are currently viewing Version 1 of this article (September 17, 2020 - 11:25).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Edward Mountjoy1,2,
- Ellen M. Schmidt1,2,
- Miguel Carmona2,3,
- Gareth Peat2,3,
- Alfredo Miranda2,3,
- Luca Fumis2,3,
- James Hayhurst2,3,
- Annalisa Buniello2,3,
- Jeremy Schwartzentruber1,2,3,
- Mohd Anisul Karim1,2,
- Daniel Wright1,2,
- Andrew Hercules2,3,
- Eliseo Papa4,
- Eric Fauman5,
- Jeffrey C. Barrett1,2,
- John A. Todd6,
- David Ochoa2,3,
- Ian Dunham1,2,3 and
- Maya Ghoussaini1,2,*
- 1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK
- 2Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
- 3European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
- 4Systems Biology, Biogen, Cambridge, MA, 02142, United States
- 5Integrative Biology, Internal Medicine Research Unit, Pfizer Worldwide Research, Development and Medical, Cambridge, MA 02139, United States
- 6Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK
- ↵*Corresponding author; email: mg29{at}sanger.ac.uk